Evidence map›Paper›PMID 24777145›Full record

ArticleVirchows Archiv : an international journal of pathology2014

Thyroglossal duct cyst cancer most likely arises from a thyroid gland remnant.

Esther D Rossi, Maurizio Martini, Patrizia Straccia, Alessandra Cocomazzi, Ilaria Pennacchia, Luca Revelli, Armando Rossi, Celestino Pio Lombardi, Luigi M Larocca, Guido Fadda

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Ectopic thyroid with benign and malignant findings: A case series.International journal of surgery case reports · 2020
    Article
  10. BRAFUpdates in surgery · 2019
    Article
  11. [Definition of R1 resection in thyroid carcinoma].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2017
    Review
  12. The extent of surgery in thyroglossal cyst carcinoma.Langenbeck's archives of surgery · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Mucoepidermoid carcinoma in a thyroglossal duct remnant.International journal of surgery case reports · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Esther D RossiDivision of Anatomic Pathology and Histology, Università Cattolica del Sacro Cuore, "Agostino Gemelli" School of Medicine, Largo Francesco Vito, 1-00168, Rome, Italy, esther.rossi@rm.unicatt.it.
Maurizio Martini
Patrizia Straccia
Alessandra Cocomazzi
Ilaria Pennacchia
Luca Revelli
Armando Rossi
Celestino Pio Lombardi
Luigi M Larocca
Guido Fadda
Università Cattolica del Sacro Cuore · ITAgostino Gemelli University Polyclinic · ITOspedale Misericordia - Grosseto · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroglossal duct cancer is a rare entity, occurring in 1.5 % of all thyroglossal duct cysts (TDC). A definitive consensus about its neoplastic origin has not been established as two contrasting theories exist, one proposing an origin in extra-thyroid remnants and the other a metastatic localization of a primary thyroid cancer. We compare morphological and molecular characteristics of both thyroglossal and thyroid carcinomas in a case series from our institute. We evaluated histology of 80 TDC. In 12 cases, prior cytological evaluation had been performed by liquid-based cytology (LBC). The BRAF gene was examined for mutations, and the histology of both thyroglossal duct and synchronous thyroid carcinoma was reevaluated. In 9 out of 80 (11 %) TDC cases, a papillary thyroid cancer (PTC) was diagnosed. In five out of nine (56 %) thyroglossal carcinomas, a synchronous thyroid cancer was diagnosed: 3 PTC and 2 follicular variant PTC (FVPC). In five thyroglossal carcinomas, mutated BRAF (V600E) was found, three in PTC and in thyroglossal as well as in the synchronous tumor in the thyroid. All the patients are in a disease-free status and still alive. Our results suggest that the majority of thyroglossal carcinomas most likely develop as a primary malignancy from a thyroid remnant. Neither the presence of V600E BRAF mutations nor that of a well-differentiated thyroid carcinoma changed the outcome or disease-free survival. We suggest that a diagnosis of thyroglossal carcinoma should be followed by a detailed evaluation of the thyroid gland. In the absence of clinical and radiological thyroid alterations, follow-up as for thyroid cancer is the correct management.

Indexed as

Adenocarcinoma, FollicularAdolescentAdultAgedBiopsy, Fine-NeedleCarcinomaCarcinoma, PapillaryDisease-Free SurvivalFemaleHumansMaleMiddle AgedProto-Oncogene Proteins B-rafThyroglossal CystThyroid Cancer, PapillaryThyroid GlandBRAF protein, humanProto-Oncogene Proteins B-raf

Identifiers

PMID24777145
OpenAlexW2083990056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.